Distribution of expenditure on cancer drugs in Italy 2020, by type
In 2020, almost all the expenditure on oncological drugs in Italy was directed towards brand name drugs. They accounted, in fact, for 94.7 percent of the total spending, whereas spending on off-patent medicines represented the remaining 5.3 percent. This statistic displays the distribution of expenditure on cancer drugs in Italy in 2020, by type.
